Toxicity Concerns Associated with the Radiopharmaceuticals for the Diagnosis of Alzheimer's Disease.

作者信息

Verma Shristy, Malviya Rishabha, Sridhar Sathvik Belagodu

机构信息

School of Medical and Allied Sciences, Galgotias University, Department of Pharmacy, India.

RAK College of Pharmacy, RAK Medical & Health Sciences University, Clinical Pharmacy and Pharmacology, United Arab Emirates.

出版信息

Cent Nerv Syst Agents Med Chem. 2025;25(2):83-86. doi: 10.2174/0118715249340822240828065449.

DOI:10.2174/0118715249340822240828065449

PMID:39248065

Abstract

摘要

相似文献

[1]

Toxicity Concerns Associated with the Radiopharmaceuticals for the Diagnosis of Alzheimer's Disease.

Cent Nerv Syst Agents Med Chem. 2025

[2]

18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).

Cochrane Database Syst Rev. 2017-11-22

[3]

Recent Advances in the Diagnosis of Alzheimer's Disease: A Brief Overview of Tau PET Tracers in Nuclear Medicine.

Curr Radiopharm. 2025

[4]

Differential diagnosis between Alzheimer's and frontotemporal disease by the posterior cingulate sign.

J Nucl Med. 2004-5

[5]

¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).

Cochrane Database Syst Rev. 2015-1-28

[6]

Combined Analysis of CSF Tau Levels and [(123)I]Iodoamphetamine SPECT in Mild Cognitive Impairment: Implications for a Novel Predictor of Alzheimer's Disease.

Am J Psychiatry. 2002-3

[7]

Dynamic relationships between age, amyloid-β deposition, and glucose metabolism link to the regional vulnerability to Alzheimer's disease.

Brain. 2016-8

[8]

Impact of (18)FDG PET and (11)C-PIB PET brain imaging on the diagnosis of Alzheimer's disease and other dementias in a regional memory clinic in Hong Kong.

Hong Kong Med J. 2016-8

[9]

Multi-region analysis of longitudinal FDG-PET for the classification of Alzheimer's disease.

Neuroimage. 2012-1-6

[10]

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease.

Brain. 2009-5

本文引用的文献

[1]

Evaluation of 10-minute post-injection 11C-PiB PET and its correlation with 18F-FDG PET in older adults who are cognitively healthy, mildly impaired, or with probable Alzheimer's disease.

Braz J Psychiatry. 2022-8-15

[2]

Near-Infrared Fluorescent Probes as Imaging and Theranostic Modalities for Amyloid-Beta and Tau Aggregates in Alzheimer's Disease.

J Med Chem. 2022-7-14

[3]

Radiopharmaceuticals for PET and SPECT Imaging: A Literature Review over the Last Decade.

Int J Mol Sci. 2022-4-30

[4]

Interaction between Aβ and Tau in the Pathogenesis of Alzheimer's Disease.

Int J Biol Sci. 2021

[5]

PET Radiopharmaceuticals for Alzheimer's Disease and Parkinson's Disease Diagnosis, the Current and Future Landscape.

Molecules. 2020-2-21

[6]

Tau PET imaging with F-PI-2620 in Patients with Alzheimer Disease and Healthy Controls: A First-in-Humans Study.

J Nucl Med. 2019-11-11

[7]

Repurposing radiotracers for myelin imaging: a study comparing 18F-florbetaben, 18F-florbetapir, 18F-flutemetamol,11C-MeDAS, and 11C-PiB.

Eur J Nucl Med Mol Imaging. 2020-2

[8]

F-labeled radiopharmaceuticals for the molecular neuroimaging of amyloid plaques in Alzheimer's disease.

Am J Nucl Med Mol Imaging. 2018-8-20

[9]

F-FIBT may expand PET for β-amyloid imaging in neurodegenerative diseases.

Mol Psychiatry. 2020-10

[10]

Radiotracers for Amyloid Imaging in Neurodegenerative Disease: State-of-the-Art and Novel Concepts.

Curr Med Chem. 2018

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

Toxicity Concerns Associated with the Radiopharmaceuticals for the Diagnosis of Alzheimer's Disease.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

本文引用的文献